secwatch.observer — SEC 8-K summary
======================================

Issuer:     Invivyd, Inc. (IVVD)
CIK:        0001832038
Form:       8-K
Filed at:   2025-09-24T23:59:59+00:00
Accession:  0001193125-25-215541
Event type: leadership
Sentiment:  positive
Materiality: 0.70
Item codes: 5.02, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Invivyd appoints Paul B. Bolno, M.D. to board; regains Nasdaq compliance
------------------------------------------------------------------------

- Dr. Bolno, President and CEO of Wave Life Sciences, appointed to Board and Compensation Committee effective September 22, 2025.
- He receives $40,000 annual cash retainer, $5,000 for committee service, and 100,000 stock options vesting over three years.
- Christine Akinc resigned from Board and all committees on September 22; departure not due to any disagreement.
- Nasdaq notified Invivyd on September 22 that it regained compliance with the $1.00 minimum bid price requirement, closing the matter.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1832038/000119312525215541/0001193125-25-215541-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1832038/000119312525215541/ivvd-20250922.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-215541

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer